(Q39883455)
Statements
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner (English)
Marileila Varella-Garcia
Thomas W Flaig
Lih-Jen Su
Caroline McCoach
Yuan Li
10 February 2009